Decatur Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,320
Closed -$1.79M 49
2024
Q1
$1.79M Sell
3,320
-33
-1% -$18K 0.97% 32
2023
Q4
$1.86M Buy
3,353
+161
+5% +$75.6K 1.12% 29
2023
Q3
$1.4M Hold
3,192
1.01% 36
2023
Q2
$1.6M Sell
3,192
-34
-1% -$16.3K 1.1% 32
2023
Q1
$1.61M Sell
3,226
-522
-14% -$250K 1.22% 26
2022
Q4
$1.53M Sell
3,748
-2
-0.1% -$776 1.1% 35
2022
Q3
$1.22M Buy
3,750
+751
+25% +$276K 0.92% 42
2022
Q2
$1.05M Buy
2,999
+9
+0.3% +$3.67K 0.78% 47
2022
Q1
$1.64M Buy
2,990
+277
+10% +$146K 0.95% 35
2021
Q4
$1.79M Sell
2,713
-23
-0.8% -$14.4K 1.06% 30
2021
Q3
$1.7M Sell
2,736
-3,226
-54% -$2.17M 1.12% 26
2021
Q2
$3.77M Hold
5,962
1.18% 24
2021
Q1
$2.92M Sell
5,962
-12,499
-68% -$6.26M 1.01% 39
2020
Q4
$9.23M Sell
18,461
-425
-2% -$190K 1.69% 12
2020
Q3
$7.42M Buy
18,886
+3,335
+21% +$1.23M 1.46% 18
2020
Q2
$5.13M Buy
15,551
+3,825
+33% +$1.11M 1.36% 24
2020
Q1
$2.84M Sell
11,726
-3,000
-20% -$783K 0.95% 50
2019
Q4
$3.85M Sell
14,726
-200
-1% -$52.7K 0.88% 53
2019
Q3
$4.06M Buy
+14,926
New +$4.15M 1% 47

Other funds holding IDXX

Decatur Capital Management's IDXX Position: Q2 2024 in Review

Decatur Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 3,320 shares — an estimated $1.79M sold.

Decatur Capital Management first reported a position in IDXX in Q3 2019 and held it in 19 quarters. The position peaked at $9.23M in Q4 2020. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Decatur Capital Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Decatur Capital Management sold 3,320 Idexx Laboratories shares in Q2 2024, an estimated $1.79M.
  • Decatur Capital Management first reported a position in Idexx Laboratories in Q3 2019 and held it in 19 quarters.
  • Decatur Capital Management's Idexx Laboratories position peaked at $9.23M in Q4 2020.
  • 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Decatur Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.